Ileana Popa

Array ( [id] => 8756063 [patent_doc_number] => 20130090369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'TRANSFECTION SHEETS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/574030 [patent_app_country] => US [patent_app_date] => 2011-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9404 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8784963 [patent_doc_number] => 08431806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Liposomal formulations of anthracycline agents and cytidine analogs' [patent_app_type] => utility [patent_app_number] => 13/237807 [patent_app_country] => US [patent_app_date] => 2011-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 10680 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13237807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854273 [patent_doc_number] => 20130143948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'MST1 AS A PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET IN HUMAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/816917 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10623 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757179 [patent_doc_number] => 20120029062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/136498 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11093 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029062.pdf [firstpage_image] =>[orig_patent_app_number] => 13136498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323425 [patent_doc_number] => 20120195834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'METHOD OF TESTING A DRUG FOR ANTI-CANCER ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/196201 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9167 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13196201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8894071 [patent_doc_number] => 20130167255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'SCREENING METHOD FOR ANTICANCER DRUGS' [patent_app_type] => utility [patent_app_number] => 13/812715 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11984 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034952 [patent_doc_number] => 20130237590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'ASSESSING THYROID NEOPLASMS' [patent_app_type] => utility [patent_app_number] => 13/810363 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7989 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13810363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566868 [patent_doc_number] => 20110286931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'CARDIAC ARRHYTHMIA TREATMENT METHODS AND BIOLOGICAL PACEMAKER' [patent_app_type] => utility [patent_app_number] => 13/167141 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 27546 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20110286931.pdf [firstpage_image] =>[orig_patent_app_number] => 13167141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488100 [patent_doc_number] => 20110251267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'METHODS OF USING POLYNUCLEOTIDES ENCODING TRUNCATED GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR' [patent_app_type] => utility [patent_app_number] => 13/167419 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22878 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251267.pdf [firstpage_image] =>[orig_patent_app_number] => 13167419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8975997 [patent_doc_number] => 20130209427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'HAIR FOLLICLE NEOGENESIS' [patent_app_type] => utility [patent_app_number] => 13/704431 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 30319 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063057 [patent_doc_number] => 20110245492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'NOVEL ALLELIC VARIANT OF CYP2C19 ASSOCIATED WITH DRUG METABOLISM' [patent_app_type] => utility [patent_app_number] => 13/108337 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8323 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245492.pdf [firstpage_image] =>[orig_patent_app_number] => 13108337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579844 [patent_doc_number] => 20110293727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'CHIMERIC THERAPEUTICS, COMPOSITIONS, AND METHODS FOR USING SAME' [patent_app_type] => utility [patent_app_number] => 13/083226 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 52979 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293727.pdf [firstpage_image] =>[orig_patent_app_number] => 13083226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586976 [patent_doc_number] => 20130005797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'ENDOSOMOLYTIC POLY(AMIDOAMINE) DISULFIDE POLYMERS FOR THE DELIVERY OF OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/634579 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6108 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101717 [patent_doc_number] => 20110165209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'Methodology and Composition for a Skin Lubricant' [patent_app_type] => utility [patent_app_number] => 13/047760 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11114 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165209.pdf [firstpage_image] =>[orig_patent_app_number] => 13047760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754791 [patent_doc_number] => 20120027841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'NOVEL MUCOSAL VACCINATION APPROACH FOR HERPES SIMPLEX VIRUS TYPE-2' [patent_app_type] => utility [patent_app_number] => 13/044379 [patent_app_country] => US [patent_app_date] => 2011-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26643 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027841.pdf [firstpage_image] =>[orig_patent_app_number] => 13044379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516288 [patent_doc_number] => 20120315696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'METHOD FOR THE PRODUCTION OF Ad26 ADENOVIRAL VECTORS' [patent_app_type] => utility [patent_app_number] => 13/578763 [patent_app_country] => US [patent_app_date] => 2011-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14788 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792768 [patent_doc_number] => 20130109737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'MEDIATOR AND COHESIN CONNECT GENE EXPRESSION AND CHROMATIN ARCHITECTURE' [patent_app_type] => utility [patent_app_number] => 13/578114 [patent_app_country] => US [patent_app_date] => 2011-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 44194 [patent_no_of_claims] => 170 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6052874 [patent_doc_number] => 20110209227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHODS FOR THE DIAGNOSIS AND TREATMENT OF BONE DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/021661 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 43778 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20110209227.pdf [firstpage_image] =>[orig_patent_app_number] => 13021661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323869 [patent_doc_number] => 20120196282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'METHOD OF REGENERATING ELASTIC FIBER AND SCREENING METHOD' [patent_app_type] => utility [patent_app_number] => 13/015871 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12343 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13015871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958592 [patent_doc_number] => 20110182979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'In-Vivo Non-Viral Gene Delivery of Human Vascular Endothelial Growth Factor Following Islet Transplantation' [patent_app_type] => utility [patent_app_number] => 13/014926 [patent_app_country] => US [patent_app_date] => 2011-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10414 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182979.pdf [firstpage_image] =>[orig_patent_app_number] => 13014926 [rel_patent_id] =>[rel_patent_doc_number] =>)